These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33748950)

  • 41. Outcomes of three patients with intracranially invasive sino-orbital aspergillosis.
    Yoon JS; Park HK; Cho NH; Lee SY
    Ophthalmic Plast Reconstr Surg; 2007; 23(5):400-6. PubMed ID: 17881994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia: one step ahead ibrutinib.
    Molica S; Gianfelici V; Levato L
    Expert Opin Emerg Drugs; 2020 Mar; 25(1):25-35. PubMed ID: 31996046
    [No Abstract]   [Full Text] [Related]  

  • 43. Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
    Roux C; Thyss A; Gari-Toussaint M
    J Mycol Med; 2013 Dec; 23(4):270-3. PubMed ID: 24210582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cavitary lung lesions in an immunosuppressed patient].
    Cabrerizo-Soto JF; Jiménez-Mejías ME; Cisneros-Herrero JM; de Francisco-Ramírez JL; Fernández-Alonso J; Cuello-Contreras JA
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):457-9. PubMed ID: 8260520
    [No Abstract]   [Full Text] [Related]  

  • 45. Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes.
    Rhodes JM; LoRe VA; Mato AR; Chong EA; Barrientos JC; Gerson JN; Barta SK; Landsburg DJ; Nasta SD; Svoboda J; Loren AW; Schuster SJ
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):438-444.e1. PubMed ID: 32197990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebral aspergillosis in children. Report of three cases.
    Cuccia V; Galarza M; Monges J
    Pediatr Neurosurg; 2000 Jul; 33(1):43-8. PubMed ID: 11025422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
    Greil R; Tedeschi A; Moreno C; Anz B; Larratt L; Simkovic M; Gill D; Gribben JG; Flinn IW; Wang Z; Cheung LWK; Nguyen AN; Zhou C; Styles L; Demirkan F
    Ann Hematol; 2021 Jul; 100(7):1733-1742. PubMed ID: 34018029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cerebral and renal aspergillosis in a patient with orthotopic heart transplant: diagnosis, treatment and follow-up].
    Boriani G; Mirri A; Iacobitti P; Magnani G; Ferretti RM; Gamba A; Mamprin F; Fiocchi R; Ferrazzi P; Binetti G
    Cardiologia; 1989 Sep; 34(9):807-11. PubMed ID: 2691078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary aspergillosis in an immunocompetent patient.
    Ko JP; Kim DH; Shepard JA
    J Thorac Imaging; 2002 Jan; 17(1):70-3. PubMed ID: 11828215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspergillus fumigatus fungus ball in a patient with healed paracoccidioidomycosis.
    Severo LC; Porto NS; Irion K; Londero AT
    Clin Infect Dis; 1997 Dec; 25(6):1474-5. PubMed ID: 9431402
    [No Abstract]   [Full Text] [Related]  

  • 51. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.
    Michallet AS; Letestu R; Le Garff-Tavernier M; Aanei C; Ticchioni M; Dilhuydy MS; Subtil F; Rouille V; Mahe B; Laribi K; Villemagne B; Salles G; Tournilhac O; Delmer A; Portois C; Pegourie B; Leblond V; Tomowiak C; De Guibert S; Orsini Piocelle F; Banos A; Carassou P; Cartron G; Fornecker LM; Ysebaert L; Dartigeas C; Truchan-Graczyk M; Vilque JP; Aurran T; Cymbalista F; Lepretre S; Levy V; Nguyen-Khac F; Feugier P
    Blood; 2021 Feb; 137(8):1019-1023. PubMed ID: 33167024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.
    de Jong J; Mitselos A; Jurczak W; Cordoba R; Panizo C; Wrobel T; Dlugosz-Danecka M; Jiao J; Sukbuntherng J; Ouellet D; Hellemans P
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00649. PubMed ID: 32945596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic necrotizing pulmonary aspergillosis.
    Parra I; Remacha A; Rezusta A; Suarez D; Suarez J; Herreras JA; González JR
    Med Mycol; 2004 Aug; 42(4):369-71. PubMed ID: 15473363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.
    Asawa P; Chahine Z; Vusqa U; Samhouri Y; Fazal S
    J Oncol Pharm Pract; 2022 Oct; 28(7):1654-1658. PubMed ID: 35253502
    [No Abstract]   [Full Text] [Related]  

  • 56. In Human Visualization of Ibrutinib-Induced CLL Compartment Shift.
    Mayerhoefer ME; Haug A; Jäger U; Pichler V; Pfaff S; Wester HJ; Hacker M; Kazianka L; Staber PB
    Cancer Immunol Res; 2020 Aug; 8(8):984-989. PubMed ID: 32580942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Images in clinical medicine. Aspergilloma.
    Ulusakarya A
    N Engl J Med; 2002 Jan; 346(4):256. PubMed ID: 11807150
    [No Abstract]   [Full Text] [Related]  

  • 58. Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
    Morabito F; Tripepi G; Del Poeta G; Mauro FR; Reda G; Sportoletti P; Laurenti L; Coscia M; Herishanu Y; Bossio S; Varettoni M; Murru R; Chiarenza A; Visentin A; Condoluci A; Moia R; Pietrasanta D; Loseto G; Consoli U; Scortechini I; Rossi FM; Zucchetto A; Al-Janazreh H; Vigna E; Martino EA; Cassin R; D Arrigo G; Galimberti S; Rago A; Angeletti I; Biagi A; Del Giudice I; Bomben R; Neri A; Fronza G; Monti P; Menichini P; Olivieri J; Cutrona G; Rossi D; Cuneo A; Di Raimondo F; Gaidano G; Polliack A; Trentin L; Foà R; Ferrarini M; Gattei V; Gentile M
    Am J Hematol; 2021 Aug; 96(8):E269-E272. PubMed ID: 33878220
    [No Abstract]   [Full Text] [Related]  

  • 59. Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL.
    Hochman MJ; Martin DB
    Ann Hematol; 2021 Feb; 100(2):579-580. PubMed ID: 32548659
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cerebral aspergillosis].
    Yamaguchi H
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):304-7. PubMed ID: 10201208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.